Skip to content

United Kingdom · Advanced Manufacturing Lvl3

Rapidx Bio Ltd

Rapidx Bio Ltd is a UK early-stage company with 6 public funding or programme announcements on record, most recently 1 Aug 2026.

Companies House record (14552565)

Announcements

  • Innovate UK funding awarded

    £501,999 · Collaborative R&D grant; “VERIFIABLE-PCR: Verified Edge Resilience for Isolated yet Auditable Biomedical Lifecycle E”; East of England

  • Innovate UK funding awarded

    £699,699 · Grant for R&D; “BioSense-X: Reusable OECT Biosensing Components for Smart Electronic Platforms”; East of England

  • Innovate UK funding awarded

    £699,917 · Investment Accelerator grant; “Democratising <10 Minute Detection and Treatment for Respiratory Tract Infections by Using”; East of England

  • Innovate UK funding awarded

    £99,978 · Collaborative R&D grant; “Low-Cost, Microfluidic-Free Diagnostic Cartridges via Photothermal Sealant Control: A Manu”; East of England

  • Innovate UK funding awarded

    £75,390 · Collaborative R&D grant; “Engineering Nanorod–Wax Metamaterials to Enable Scalable, Microfluidics-Free Molecular Dia”; East of England

  • Innovate UK funding awarded

    £244,608 · Collaborative R&D grant; “Feasibility for Instantaneous, Large Scale, Low Cost and Field-Ready Hyperspectral Monitor”; Wales

Is this your company?

Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.

Not a recommendation

Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.

All start-ups in Ireland and the UK